Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme

This study has been terminated.
(Loss of funding)
Sponsor:
Collaborator:
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00227032
First received: September 23, 2005
Last updated: March 5, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)